Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
91.20
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
90.98
-0.22 (-0.24%)
After-hours: Mar 9, 2026, 7:17 PM EDT
Guardant Health Revenue by Segment
History
| Date | Oncology | Precision Oncology Testing | Biopharma and Data | Screening | Development Services | Licensing and Other |
|---|---|---|---|---|---|---|
| Dec 31, 2025 | 683.60M | 687.94M | 210.13M | 79.73M | 51.08M | 8.56M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.